SUBSCRIBE
SUBSCRIBE
News   Deals

Novacea Cuts IPO Share Price To $6.50 From $11-13

May 9, 2006 | 
1 min read
Development stage drug maker Novacea Inc. on Tuesday cut its expected initial public offering share price to $6.50 a share from $11 to $13 a share, according to a regulatory filing on Tuesday.
IPO
MORE ON THIS TOPIC
Contemporary art collage of woman sitting in the lotus position, cloud, pillows against the background of the night sky. Concept of healthy lifestyle and sport. Good and relaxing sleep. Copy space.
Mergers & acquisitions
Another Bidding War Breaks as Lundbeck Bids for Sleep Biotech Avadel
November 14, 2025
 · 
1 min read
 · 
Annalee Armstrong
Investment mistakes, taxes, expenses, and unknown costs drain money, concept of Businessman carries a money bag with a big hole, banknotes falling out
Mergers & acquisitions
Merck Again Brings Out Big Bucks, Buys Cidara in $9.2B Antiviral Push
November 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Upward arrow on the background of the flag of China. Paper plane. Economic recovery. Copy space. Business. Background.
China
Recently Launched Third Arc Turns to China for Cancer T Cell Engagers
November 13, 2025
 · 
2 min read
 · 
Tristan Manalac
too many different pill of various blisters with different pills Medicines storage at home concept Medication storing. A pile of medicine in blister packs. Pharmaceutical blister packs.
Drug Development
Five Trends That Got Everyone Talking in Pharma and Biotech This Year
November 12, 2025
 · 
5 min read
 · 
Jennifer Smith-Parker